Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Goddard Colin
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Endocyte, Inc.
Human Genome Sciences Inc.
OSI Pharmaceuticals Inc.
OSI Pharmaceuticals Inc.
Chief Executive Officer, Director
Avg. Two Year Performance
No Purchase Track Record
14%
Avg. Sale Return
7%
Compound
Holdings: 0 shares
Last Three Months: 23-Aug-24 -- 22-Nov-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
23-Nov-22 -- 22-Nov-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions
